et al has reported that IGF/STAT3/Nanog/Slug axis induces the progression of EMT and self-renewal of CSCs, and may serve as potential therapeutic targets for colon cancer therapy [171]. The gene discussed is IGF1; the disease is malignant colon neoplasm.